Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The Role of Mitochondrial TNAP in Adaptive Thermogenesis

Award Number: K01DK132455
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 12/01/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2026
AWARD TERMINATION DATE: 02/19/2026

Group Awards By:

View Award Description

The Role of Mitochondrial TNAP in Adaptive Thermogenesis - Abstract Thermogenic adipocytes and adaptive thermogenesis are promising therapeutic targets for treating and preventing obesity and obesity-linked diabetes. We recently demonstrated that the mitochondrial tissue- nonspecific alkaline phosphatase, TNAP, plays a crucial role in the futile creatine cycle (FCC) and adaptive thermogenesis by hydrolyzing phosphocreatine. Pharmacological inhibition or genetic ablation of TNAP in mice reduces systemic energy expenditure. Genetic ablation of TNAP in mice also causes rapid-onset obesity. TNAP assumes a mitochondrial localization specifically in thermogenic adipocytes, which might ensure the cell- selectivity of the phosphocreatine hydrolysis events and the FCC operation. Here, we propose to study the metabolic effects of gain-of- function of TNAP in the adipose tissues in mice, as well as the molecular mechanism and regulation of its mitochondrial localization. Using a transgenic mouse strain that artificially expresses TNAP in the adipose tissues, we will investigate its effects on obesity, diabetes, fatty liver, and energy expenditure. To study the TNAP localization, we will test whether its cell specificity lies in the TNAP polypeptide or its trafficking pathway, or both. I will first determine whether there are any molecular elements (e.g., PTMs or amino acid sequences) on the TNAP polypeptide crucial for its mitochondrial localization. This will be done using a combination of biochemical and cell imaging approaches. In addition, we will investigate the cellular pathway of TNAP trafficking to mitochondria. We will interrogate the role of lipid rafts in TNAP localization. This might allow us to identify key regulators and mediators of the mitochondrial localization of TNAP. Finally, we will identify other mitochondrial proteins that share the localization pathway of TNAP and study their functions. The candidate, Dr. Yizhi Sun, has a strong track record of innovative research with a focus on the molecular mechanisms of diseases. The candidate’s career goal is to become an independent academic investigator with a research laboratory oriented towards understanding and reversing obesity and obesity-linked metabolic disorders. The proposed research will be conducted in the laboratory of Bruce Spiegelman, PhD at Dana-Farber Cancer Institute and Harvard Medical School, who is a leader in the fields of molecular metabolism and adipocyte biology. The proposed studies will also bring together leading laboratories of the advisory committee that have expertise in cell imaging, protein trafficking, and mitochondrial biology. All of these, together with the ideal research environment in the Longwood Medical Area, will maximize applicant’s potential to successfully transition to an independent investigator.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF ARKANSAS	1125 W MAPLE ST STE 316	FAYETTEVILLE	AR	72701	WASHINGTON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	004	4	4/13/2026	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$57,196
2026	2025	UNIVERSITY OF ARKANSAS	1125 W MAPLE ST STE 316	FAYETTEVILLE	AR	72701	WASHINGTON	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	005	4	4/15/2026	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$1
2026	2025	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	1/30/2026	NON-COMPETING CONTINUATION	-$57,196
2026	2025	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	002	3	4/3/2026	TERMINATION	-$57,196
2026	2025	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	003	3	4/9/2026	TERMINATION	$1
2026	2025	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	3	2/18/2026	TERMINATION	$57,196
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $127,781 )
2025	2025	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	11/13/2024	NON-COMPETING CONTINUATION	$127,781
														Subtotal = $127,781

Issue Date FY: 2024 ( Subtotal = $127,781 )
2024	2024	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	11/8/2023	NON-COMPETING CONTINUATION	$127,781
														Subtotal = $127,781

Issue Date FY: 2023 ( Subtotal = $129,001 )
2023	2023	DANA-FARBER CANCER INSTITUTE, INC.	450 BROOKLINE AVE	BOSTON	MA	02115	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	11/30/2022	NEW	$129,001
														Subtotal = $129,001

Grand Total All Awards = $384,563

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of Mitochondrial TNAP in Adaptive Thermogenesis

Award Number: K01DK132455

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 12/01/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2026

AWARD TERMINATION DATE: 02/19/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer